| abstract |
Multifunctional beta-antagonist compounds are provided, that combine β-adrenergic receptor blocking activity with capability to scavenge superoxide and other reactive oxygen species, and that may further function as nitric oxide donors. The compounds are useful for preventing or treating disorders in which the treatment with β-antagonists is indicated, or which are associated with oxidative stress. |